Michael Alan Horberg, MD, MAS, FACP, FIDSA is Associate Medical Director for Kaiser Permanente Mid-Atlantic Permanente Medical Group (MAPMG). In that role, is responsible for Research, Medical Education, Community Health, Medicaid, Genetics, HIV and STD, Transgender Health and Infection Control and Prevention. He serves as the Executive Director of the Mid-Atlantic Permanente Research Institute (MAPRI). As Executive Director of Mid-Atlantic Permanente Research Institute (MAPRI), Dr. Horberg is responsible for all research activities in Kaiser Permanente Mid-Atlantic States (KPMAS). As Associate Medical Director for Medical Education, he is the Designated Institutional Official for KPMAS, with responsibility for all undergraduate and graduate medical education in KPMAS.

Dr. Horberg serves as the medical director for KPMAS Community Health, as well is the Medicaid leader for MAPMG, including Chief Medical Officer for KPMAS in Maryland Medicaid. He leads HIV, STD, Infection Prevention, and transgender health care efforts in the KPMAS region, and HIV and STD care program-wide for Kaiser Permanente. He leads the opening of Pride Medical and KPMAS’ Gender Pathways programs and clinics within KPMAS. Dr. Horberg leads the Medical Genetics and Genomics strategy for MAPMG and is Executive Sponsor for KPMAS’ Commission on Cancer Accreditation and National Surgical Quality Improvement Program.

Dr. Horberg serves as director of HIV/AIDS program-wide for Kaiser Permanente and as Clinical Lead for HIV/AIDS and STDs for the Care Management Institute. Under President Obama, Dr. Horberg served on the Presidential Advisory Council on HIV/AIDS, and co-chaired the Access to Care and Improved Outcomes Committee. Dr. Horberg is a Fellow of the American College of Physicians and the Infectious Disease Society of America (IDSA). He is Past-Chair of the Board of Directors of the HIV Medicine Association (HIVMA) of IDSA. He has served on the IDSA Quality Performance Committee, and presently co-chairs the IDSA Primary Care Guideline Committee. Dr. Horberg served as a commissioner on the State of Maryland Natalie M. LaPrade Medical Cannabis Commission. He is past-president of the national Gay and Lesbian Medical Association.

In his role as Executive Director of MAPRI, Dr. Horberg leads a department of both clinical and data research with over sixty team members. His HIV research interests are health service outcomes for HIV-infected patients (including HIV quality measures and care improvement, and determinants of optimized multidisciplinary care for maximized HIV outcomes), medication adherence issues in these patients, and epidemiology of the disease. Dr. Horberg serves as the MAPRI and national principal investigator for the Kaiser Permanente Research Bank (genomics initiative). Other research interests include other sexually transmitted diseases and hepatitis. Dr. Horberg has published over 180 manuscripts and delivered over 100 presentations at scientific meetings; all are in peer-reviewed literature or conferences. He has chaired multiple Expert Panels on HIV-related provider performance measures (including ones sponsored by CMS, NCQA, and IDSA), and has served on NIH and CDC peer-review panels.

A Chicagoan by birth, Dr. Horberg attended Boston University Medical School, and received his Master of Advanced Studies, from University of California San Francisco. He completed his residency in internal medicine (categorical) at University of Chicago Michael Reese Hospital and Medical Center. He is a resident of the District of Columbia with his husband Chip and their pet poodle Grant.